Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis. (Q54549498)

31 May 2018

title

Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis. (English)

1 reference

31 May 2018

0 references

Maria Serena Longhi

1

1 reference

31 May 2018

Francesca Meda

2

1 reference

31 May 2018

Pengyun Wang

3

1 reference

31 May 2018

Marianne Samyn

4

1 reference

31 May 2018

Giorgina Mieli-Vergani

5

1 reference

31 May 2018

Diego Vergani

6

1 reference

31 May 2018

Yun Ma

7

1 reference

31 May 2018

language of work or name

English

0 references

publication date

1 February 2008

1 reference

31 May 2018

published in

Hepatology

1 reference

31 May 2018

volume

47

1 reference

31 May 2018

issue

2

1 reference

31 May 2018

page(s)

581-591

1 reference

31 May 2018

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells

cites work

1 reference

Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis.

21 January 2018

1 reference

Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells

21 January 2018

1 reference

From vanilla to 28 flavors: multiple varieties of T regulatory cells

21 January 2018

1 reference

7 January 2021

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

1 reference

7 January 2021

Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells

1 reference

7 January 2021

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

1 reference

7 January 2021

An essential role for Scurfin in CD4+CD25+ T regulatory cells

1 reference

7 January 2021

Foxp3 in control of the regulatory T cell lineage

1 reference

7 January 2021

Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease

1 reference

7 January 2021

Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state

1 reference

7 January 2021

Quantification of regulatory T cells in patients with systemic lupus erythematosus

1 reference

7 January 2021

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy

1 reference

7 January 2021

Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II

1 reference

7 January 2021

Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells.

1 reference

7 January 2021

In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation.

1 reference

7 January 2021

Autoimmune hepatitis in childhood: a 20-year experience.

1 reference

7 January 2021

Autoimmune hepatitis in children

1 reference

7 January 2021

Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.

1 reference

7 January 2021

Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis

1 reference

7 January 2021

Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study

1 reference

7 January 2021

Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells

1 reference

7 January 2021

The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.

1 reference

7 January 2021

Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin

1 reference

7 January 2021

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

1 reference

7 January 2021

LAT-mediated signaling in CD4+CD25+ regulatory T cell development

1 reference

7 January 2021

IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo

1 reference

7 January 2021

The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.

1 reference

7 January 2021

Th17: an effector CD4 T cell lineage with regulatory T cell ties

1 reference

7 January 2021

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

1 reference

7 January 2021

Defective regulatory and effector T cell functions in patients with FOXP3 mutations.

1 reference

7 January 2021

Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.

1 reference

7 January 2021

Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.22071

1 reference

31 May 2018

release_siinljm3xffplgeomfr7xtbmuu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/siinljm3xffplgeomfr7xtbmuu

24 November 2022

mapped directly with Wikidata item

PubMed ID

18220288

1 reference

31 May 2018